Alloreactivity studied with mutants of HLA-A2.

AUTOR(ES)

Santos-Aguado, J

RESUMO

Based on the crystal structure of HLA-A2.1 and the recognition of a panel of mutant HLA-A2.1 molecules by a large number of alloreactive cytotoxic T lymphocyte clones, a model to explain alloreactivity is described. In this model recognition of an allogeneic major histocompatibility complex molecule by a self-restricted T-cell receptor occurs as the result of accommodation by the receptor of a few amino acid differences in the major histocompatibility complex molecule--i.e., cross-recognition. Alloreactivity is the result of the presence in the foreign antigen binding site of the allogeneic major histocompatibility complex molecule of unusual self-peptides, reactivity to which could not have been eliminated by negative thymic selection.

Documentos Relacionados

• Class I-induced resistance to natural killing: identification of nonpermissive residues in HLA-A2.
• In vitro peptide binding to the heavy chain of the class I molecule of the major histocompatibility complex molecule HLA-A2.
• Structure of crossreactive human histocompatibility antigens HLA-A28 and HLA-A2: possible implications for the generation of HLA polymorphism.
• Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705.
• Calreticulin recognizes misfolded HLA-A2 heavy chains